Author/Authors :
Igal Teplitzky، نويسنده , , S.R. and Kiefer، نويسنده , , T.L. and Cheng، نويسنده , , Q. and Dwivedi، نويسنده , , P.D. and Moroz، نويسنده , , K. and Myers، نويسنده , , L. and Anderson، نويسنده , , M.B. and Collins، نويسنده , , A. and Dai، نويسنده , , J. and Yuan، نويسنده , , Cynthia L. and Spriggs، نويسنده , , L.L. and Blask، نويسنده , , D.E. and Hill، نويسنده , , S.M.، نويسنده ,
Abstract :
In experimental trials using the N-nitroso-N-methylurea (NMU)-induced rat mammary tumor model, a significant decrease in tumor incidence (to 5%) was observed in rats treated with melatonin and 9-cis-retinoic acid (9 cRA) compared to controls (55%). Although 9cRA alone decreased tumor incidence to 26%, this response did not reach statistical significance. Tumor incidence was significantly inhibited to 20% in the animals that received melatonin and 9cRA on alternating days. Latency to tumor onset was prolonged in animals receiving either of the combination treatments compared with controls, and tumor multiplicity was also significantly decreased.
